D Deandreis

Summary

Affiliation: Institut Gustave Roussy
Country: France

Publications

  1. doi request reprint Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology?
    Desiree Deandreis
    Department of Nuclear Medicine and Endocrine Oncology, Institut Gustave Roussy, Villejuif, France
    Thyroid 22:165-72. 2012
  2. doi request reprint Role of FDG PET/CT and chest CT in the follow-up of lung lesions treated with radiofrequency ablation
    Desiree Deandreis
    Department of Nuclear Medicine and Endocrine Oncology, Institute Gustave Roussy and University Paris Sud XI, 39 rue Camille Desmoulins, 94805 Villejuif, France
    Radiology 258:270-6. 2011
  3. doi request reprint Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?
    D Deandreis
    Department of Nuclear Medicine and Endocrine Oncology, National Institute of Health and Medical Research, Institut Gustave Roussy, France
    Endocr Relat Cancer 18:159-69. 2011
  4. doi request reprint FDG PET in the management of patients with adrenal masses and adrenocortical carcinoma
    Desiree Deandreis
    Department of Nuclear Medicine and Endocrine Oncology, Institut Gustave Roussy, Villejuif, France
    Horm Cancer 2:354-62. 2011
  5. doi request reprint Fluorodesoxyglucose uptake in the remaining adrenal glands during the follow-up of patients with adrenocortical carcinoma: do not consider it as malignancy
    S Leboulleux
    Department of Nuclear Medicine and Endocrine Oncology, Institut Gustave Roussy, University Paris Sud, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France
    Eur J Endocrinol 164:89-94. 2011
  6. doi request reprint Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level
    C Nascimento
    Department of Nuclear Medicine and Endocrine Oncology, Institut Gustave Roussy, Univ Paris Sud, Villejuif, France
    Endocr Relat Cancer 18:R29-40. 2011
  7. doi request reprint Therapeutic management of advanced adrenocortical carcinoma: what do we know in 2011?
    E Baudin
    Department of Nuclear Medicine and Endocrine Tumors, Institut Gustave Roussy, Univ Paris Sud, Villejuif, France
    Horm Cancer 2:363-71. 2011
  8. doi request reprint Adrenocortical carcinoma: is the surgical approach a risk factor of peritoneal carcinomatosis?
    S Leboulleux
    Department of Nuclear Medicine and Endocrine Oncology, Institut Gustave Roussy, University Paris Sud XI, 39 rue Camille Desmoulins, Villejuif Cedex, France
    Eur J Endocrinol 162:1147-53. 2010

Detail Information

Publications8

  1. doi request reprint Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology?
    Desiree Deandreis
    Department of Nuclear Medicine and Endocrine Oncology, Institut Gustave Roussy, Villejuif, France
    Thyroid 22:165-72. 2012
    ..The goal of this study was to evaluate the role of FDG-PET/computed tomography (CT) in predicting malignancy of thyroid nodules with indeterminate FNAC and to correlate FDG uptake with pathological and ultrasonographic (US) features...
  2. doi request reprint Role of FDG PET/CT and chest CT in the follow-up of lung lesions treated with radiofrequency ablation
    Desiree Deandreis
    Department of Nuclear Medicine and Endocrine Oncology, Institute Gustave Roussy and University Paris Sud XI, 39 rue Camille Desmoulins, 94805 Villejuif, France
    Radiology 258:270-6. 2011
    ..To compare fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography (PET) combined with computed tomography (PET/CT) and chest CT in the evaluation of the effectiveness of lung radiofrequency (RF) ablation...
  3. doi request reprint Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?
    D Deandreis
    Department of Nuclear Medicine and Endocrine Oncology, National Institute of Health and Medical Research, Institut Gustave Roussy, France
    Endocr Relat Cancer 18:159-69. 2011
    ..Well-differentiated thyroid cancer presenting histological features such as necrosis and FDG uptake on PET scan should be considered aggressive differentiated cancers...
  4. doi request reprint FDG PET in the management of patients with adrenal masses and adrenocortical carcinoma
    Desiree Deandreis
    Department of Nuclear Medicine and Endocrine Oncology, Institut Gustave Roussy, Villejuif, France
    Horm Cancer 2:354-62. 2011
    ..New tracers and indications for the clinical use of FDG PET in this specific disease still have to be evaluated to assess its role in clinical practice...
  5. doi request reprint Fluorodesoxyglucose uptake in the remaining adrenal glands during the follow-up of patients with adrenocortical carcinoma: do not consider it as malignancy
    S Leboulleux
    Department of Nuclear Medicine and Endocrine Oncology, Institut Gustave Roussy, University Paris Sud, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France
    Eur J Endocrinol 164:89-94. 2011
    ..To make the specificity of fluorodesoxyglucose ((18)FDG) positron emission tomography (PET) precise, in the follow-up of patients with adrenal cancer...
  6. doi request reprint Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level
    C Nascimento
    Department of Nuclear Medicine and Endocrine Oncology, Institut Gustave Roussy, Univ Paris Sud, Villejuif, France
    Endocr Relat Cancer 18:R29-40. 2011
    ..In these patients, repeating TSH-Tg 6-18 months after ablation is not useful. (131)I ablation could be avoided in the absence of N1 and aggressive histological variant...
  7. doi request reprint Therapeutic management of advanced adrenocortical carcinoma: what do we know in 2011?
    E Baudin
    Department of Nuclear Medicine and Endocrine Tumors, Institut Gustave Roussy, Univ Paris Sud, Villejuif, France
    Horm Cancer 2:363-71. 2011
    ..International networks and comprehensive databases gathering clinical and biological data constitute the prerequisites for progress...
  8. doi request reprint Adrenocortical carcinoma: is the surgical approach a risk factor of peritoneal carcinomatosis?
    S Leboulleux
    Department of Nuclear Medicine and Endocrine Oncology, Institut Gustave Roussy, University Paris Sud XI, 39 rue Camille Desmoulins, Villejuif Cedex, France
    Eur J Endocrinol 162:1147-53. 2010
    ..Peritoneal carcinomatosis (PC) is a rare site of distant metastases in patients with adrenocortical cancer (ACC). One preliminary study suggests an increased risk of PC after laparoscopic adrenalectomy (LA) for ACC...